Product
Thrombosomes
2 clinical trials
7 indications
Indication
ThrombocytopeniaIndication
hematologic malignanciesIndication
Aplastic AnemiaIndication
Myeloproliferative DisordersIndication
Myelodysplastic SyndromesIndication
Platelet RefractorinessIndication
Hematologic DisordersClinical trial
A Phase I, Multi-Center, Open-Label, Dose Escalation Study of Thrombosomes® in Bleeding Thrombocytopenic Patients in Three CohortsStatus: Completed, Estimated PCD: 2019-08-01
Clinical trial
A Prospective, Multicenter, Randomized, Open-Label Phase 2, Parallel, Dose Ranging Multidose Study of Thrombosomes® vs Liquid Stored Platelets (LSP) in Bleeding Thrombocytopenic PatientsStatus: Terminated, Estimated PCD: 2022-01-07